The present invention relates to novel compounds and compositions that modulate mGluR5 activity. The invention also relates to uses thereof for the therapeutic or prophylactic treatment of neurological disorders in mammals. In particular, the present invention includes compounds of Formula (I) or a pharmaceutical salt or solvate thereof: (see formula I)
METABOTROPIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS OF USE THEREOF